Objective: Dosimetry of singlet oxygen ( 1 O 2 ) is of particular interest because it is the major cytotoxic agent causing biological effects of type-II photosensitizers during photodynamic therapy (PDT). An in-vivo model was developed to determine the singlet oxygen threshold dose, [ Schlüsselwörter: photodynamische Therapie; Singulettsauerstoff-Produktion; Sauerstoffabhängigkeit der Singulettsauerstoff-Quantenausbeute.
Introduction
Photodynamic therapy (PDT) is an anti-cancer treatment modality based on the interaction of light, a photosensitizing drug, and oxygen [1] . PDT has been approved by the US Food and Drug Administration for the treatment of microinvasive lung cancer, obstructing lung cancer, and obstructing esophageal cancer and Barrett's esophagus with high-grade dysplasia, as well as for age-related macular degeneration and actinic keratosis [2] .
PDT is inherently a complex process in which the photosensitizer (PS), light and oxygen vary dynamically and interdependently on timescales specific to an individual treatment condition. Thus, the distribution of light is determined by the light source characteristics and the effective tissue optical absorption and scattering at the treatment wavelength. The effective absorption is affected by the local concentration of PS and the concentration and oxygenation status of the blood. The oxygen distribution is altered by photodynamic consumption and any PDT-induced changes in blood flow [3] . The effective PS concentration and distribution may change due to photobleaching. On the one hand, these effects make accurate PDT dosimetry extremely challenging, on the other hand, this is critical to achieve optimal efficacy and safety, particularly when there is curative intent, as is the case of PDT of multiple types of malignancies [4, 5] .
Most PSs available for PDT utilize type-II photodynamic processes, i.e., the photodynamic effect is achieved through the production of singlet oxygen ( 1 O 2 ) [6, 7] . The energy level diagram shown in Figure 1 summarizes the underlying physical processes involved in type-II PDT with reaction rates (k i ) defined in Table 1 . The process begins with the absorption of a photon (k 0 ) by PS in its ground state (S 0 ), promoting it to an excited state (S 1 ). The PS molecule can return to its ground state by emission of a fluorescence photon (k 3 ), which can be used for fluorescence detection. Alternatively, the molecule may convert to a triplet state, a process known as intersystem crossing (k 5 ). A high intersystem crossing yield is an essential feature of a good type-II PS. Once in its triplet state, the molecule may undergo a collisional energy transfer with ground state molecular oxygen (type II, k 2 ) or with the substrate (type-I) [6] . In type-II interaction, the PS returns to its ground state, and oxygen is promoted from its ground state (a triplet state) to its excited (singlet) state. Since the PS is not consumed in this process, the same PS molecule may create many 1 O 2 molecules. The PS triplet state can also return to the ground state spontaneously without interacting with oxygen by emitting a phosphorescence photon instead (k 4 ). Once the singlet oxygen is created, it reacts almost immediately with cellular targets in its immediate vicinity. The majority of these reactions are irreversible, and lead to consumption of oxygen. This consumption of oxygen is efficient enough to cause measurable decreases in tissue oxygenation when the incident light intensity is high enough. In addition to its reactions with cellular targets (k 7 ), singlet oxygen may react with the PS itself (k 1 ). This leads to its irreversible destruction (photobleaching). Photobleaching can decrease the effectiveness of PDT by reducing the PS concentration; however it can also be useful for dosimetry, so-called "singlet oxygen implicit dosimetry" (SOID) [9] . Because of its high reactivity, 1 O 2 has a very short lifetime (τ Δ ) in tissue. However, a small fraction of the 1 O 2 produced may return to its ground state via emission of a phosphorescence photon (k 6 , λ = 1270 nm), which can be detected optically, the so-called "singlet oxygen luminescence dosimetry" (SOLD) [10, 11] .
For type-II PSs, excited-state singlet oxygen, the major cytotoxic species causing biological effects, is generated upon the absorption of light by the PS in the presence of ground state molecular oxygen ( 3 O 2 ). Thus, direct measurement of singlet oxygen constitutes the ultimate PDT dosimetry method to correlate with PDT outcome. One method of determining the singlet oxygen is through invivo measurements of light and PS concentration, followed by calculation of the generation of singlet oxygen via a dynamic model, so-called "singlet oxygen explicit dosimetry" (SOED 
Materials and methods
In this study, k i (i = 0, 1, …, 7) are used to designate the reaction rate. The definitions associated with the reaction rates are summarized in Table 1 . 
Macroscopic kinetics rate equations
A rate equation approach first proposed by Foster et al. [12] and later refined by Hu et al. [13] was adopted to describe the PDT kinetics processes. The complete set of rate equations is published elsewhere [8, 14] . 
Note that a macroscopic oxygen perfusion rate,
 is used to replace the microscopic diffusion and metabolic consumption of oxygen in tissue in a uniform vascular structure in the macroscopic model [8, 14] , where g is the oxygen maximum perfusion rate. The specific oxygen consumption rate, [ O ]
Here the reacted singlet oxygen concentration is defined
where f is the fraction of singlet oxygen interacting with target [A], and k 7 [A] = 1/τ Δ is the inverse of the singlet oxygen lifetime in tissue. In this paper singlet oxygen f = 1 is used.
The corresponding expressions for the instantaneous concentrations of singlet oxygen, as well as singlet, and triplet states of PS are: RIF, radiation-induced fibrosarcoma; BPD, benzoporphyrin derivative monoacid ring A.
The rate equations are implemented in the MATLAB code. The calculation time is in seconds for the rate equation alone [Eqn. (2)- (7)] and minutes for the time and spatially coupled differential equation [Eq. (1)]. All these quantities are a function of space (x, y, z) and time (t).
Necrosis experiment and SOED
Through in-vivo studies of a murine radiation-induced fibrosarcoma (RIF) tumor model, the extent of necrosis that is generated by PDT with benzoporphyrin derivative monoacid ring A (BPD) was measured to determine [ 1 O 2 ] rx,sh . Two drug-light intervals (DLI), 15 min and 3 h, were used. The treatment laser wavelength was 690 nm. Table 2 summarizes the conditions that were evaluated for in-vivo PDT.
The RIF tumors were grown by the intradermal injection of 3 × 10 5 cells on the right shoulders of the mice and studies were initiated approximately 10 days later when tumors were 8-12 mm in diameter. Animal husbandry was provided by the University of Pennsylvania Laboratory Animal Resources in Association for Assessment and Accreditation of Laboratory Animal Care (AALAC)-accredited facilities according to protocols approved by the University of Pennsylvania Institutional Animal Care and Use Committee. PDT was performed using a 1-cm long cylindrical diffusing fiber (CDF) to deliver light at various fluence rates and total treatment times [14] . The mice were sacrificed 24 h after PDT and the tumors resected perpendicular to the CDF. The experimental set-up is shown in Figure 2A and B.
with hematoxylin and eosin (H&E) to show the necrotic area. Slides were then digitally scanned so that the area, Area, and radius, r, of necrosis could be outlined and determined. The radius of necrosis was found by the following calculation:
All tumors were measured immediately post-excision and just prior to sectioning for each mouse to determine the shrinkage. From this data an average shrinkage factor of 30% was incorporated into the determination of the necrotic area. The standard deviation of the radius of necrosis was found by:
N is the total number of necrosis radii examined. For areas of necrosis that were ellipsoidal in shape, multiple radii were measured from the location of the light source (indicated by the hole left behind by the CDF catheter in the tumor section) to the edge of necrosis. Standard deviations were added to the standard deviations for the radius of necrosis for each group of mice that were treated under the same conditions. For the set of experiments performed with individual mice, a set standard deviation of 0.5 mm was applied. The necrosis radius due to insertion of the 1-cm CDF alone was measured as 0.5 or 1.0 mm in nine unilluminated control mice. The radius in these controls was observed to be a function of whether a plastic catheter was used to house the 1-cm CDF during its insertion. A catheter was not used for CDF placement in most PDT-treated animals except for the ones also used for optical properties measurement. These uncertainties were included in the data analysis of the measured necrosis radius.
The optical properties (absorption, μ a , and reduced scattering, , s µ′ coefficients) of the tumor environment were determined using a two catheter method [15] . A 2-mm point source and an isotropic detector were inserted into the tumor using two parallel catheters (Figure 2A ). Light fluence data was scanned along the point source by moving the isotropic detector at various source positions. The data was then fitted with the diffusion approximation: Tumors were then sectioned perpendicularly to the direction of light delivery at 200-μm separations and 4-10 sections were placed on slides and subsequently stained measured optical properties as a second consistent check of the optical properties values. The light fluence rate at the radius of necrosis was calculated for each mouse along the radial axis with respect to the center of the CDF: 
where r is the distance to the point of interest along the radial axis given the center of the CDF as origin, l is the length of the CDF, and s is the source strength of the CDF (in mW/cm). The PS concentration in the tumor was determined using fluorescence spectra. For this, a polished side-firing fiber was inserted into the source position catheter to excite the PS with 405-nm light and collect the fluorescence signal through a dichroic beam splitter to be collected by a multi-channel spectrometer. Spectra were analyzed by using singular value decomposition methods with known phantom fluorescence spectra [17] . Optical properties correction of fluorescence signal reduction due to tissue absorption and scattering was performed using an empirical correction method [18] .
Optimization algorithm to determine
in-vivo singlet oxygen threshold dose 
where N is the total number of groups (or individual mouse for an earlier experiment) and r i is the measured radius of necrosis for group (mouse) i. In our most recent experiments, each group consisted of 3 mice with the same treatment conditions for which the radii of necrosis and other measured parameters were averaged (Table 3A) . In an earlier experiment (see Table 3B ) individual mice were used. Multi-variable optimization uses the functional minimization function "fminsearch" from MATLAB and is implemented in the same way as described elsewhere [14] . 
By evaluating Eqn. (13) for varying the initial estimate of parameters to be fit, the standard deviations of the fitted parameters were found. The sensitivity of the parameter determination depends also on the variation of necrosis for the light fluence rate and total fluence used. For a DLI of 15 min, the necrosis radii are all near 4.5 mm without substantial variability. The parameter set determined for BPD with a DLI of 15 min was considered to be "preliminary" due to the narrow range of experimental conditions that were performed. Additional experiments should be added to the study with a DLI of 3 h to improve the accuracy of the resulting parameters (ξ, σ, g, β) but it is not expected to change the conclusion that [ 1 O 2 ] rx,sh for the BPD, DLI = 15 min study is much lower than that of the BPD, DLI = 3 h study.
Results and discussion

Macroscopic modeling of singlet oxygen threshold dose
The treatment conditions for BPD are listed in Tables 3  and 4 for a DLI of 3 h and 15 min, respectively. Figures 3 and 4 show the fitting results of (A) the reacted singlet oxygen concentration [ 1 O 2 ] rx versus radius of necrosis and (B) the comparison of predicted and measured radius of necrosis for BPD for a DLI of 3 h and 15 min, respectively. The recovered photochemical parameters for the rate equations are listed in Table 5 for BPD and several other photosensitizers from the literature.
Each data point was evaluated for their quality after the fitting runs was performed. Mice, which had a lower than expected physiological concentrations of the PS were eliminated from the data analysis. In addition, light fluence rates were calculated for the distance of the detector away from the treatment linear source, using the source strength and the measured optical properties. If the calculated fluence rates deviated more than 50% from the measured fluence rate during treatment, then the data point was not considered for analysis. Table 5 for benzoporphyrin derivative monoacid ring A (BPD) with a drug-light interval of 3 h. The corresponding initial photosensitizer concentrations, source strengths for linear source (mW/cm), treatment times (s), absorption and reduced scattering coefficients, and fluence rates at radius of necrosis (mW/cm 2 ) are shown in Table 3 Table  5 for benzoporphyrin derivative monoacid ring A (BPD) with a drug-light interval of 15 min (a preliminary study). The corresponding initial photosensitizer concentrations, source strengths for linear source (mW/cm), treatment times (s), absorption and reduced scattering coefficients, and fluence rates at radius of necrosis (mW/cm 2 ) for each group of 3 mice are shown in Table 4 in vivo was obtained [29] . However, the in-vivo results are at least 20 times smaller than those observed in spheroids, indicating that factors other than singlet oxygen-mediated tumor cell kill may contribute to PDT damage for these treatment conditions [29] . The singlet oxygen threshold dose obtained for BPD with a DLI of 15 min (BPD 1 mg/ kg, 690 nm) was also included, where a vascular effect is predominant [30] . The lower singlet oxygen threshold dose of 0.12 mm that is associated with these conditions is to be expected, given the BPD concentration (∼0.15 μm) in tissue after a DLI of 15 min is much lower than that (∼0.6 μm) after administration of BPD with a DLI of 3 h [24] is based on log10. Therefore this value was converted to that based on loge by multiplying by 2.303 to be consistent with the base-e definition for extinction coefficient used here. The parameter ξ are obtained using the study of Georgakoudi et al. [20] , and Mitra and Foster [25] from tumor spheroid studies, where ξ equals to β PDT /[S 0 ]. β PDT is a proportional constant between photochemical oxygen consumption rate and the fluence rate [25] . ξ is either calculated according to the β PDT value from the literature [20, 25, 28] or based on the current mouse studies (fitted value). c These photochemical parameters are currently not available in the literature. Consequently, the value of Photofrin ® was taken. d Specific oxygen consumption rate, ξ, is the photochemical PDT oxygen consumption rate per fluence rate per PS concentration; specific photobleaching ratio, σ, is the ratio of photobleaching rate by singlet oxygen between PS and all the acceptors per PS concentration; oxygen quenching threshold concentration, β, is the value of the oxygen concentration where the quantum efficiency of singlet oxygen generation is reduced by half, following the equation (which is associated with less of a vascular effect). The fact of the matter is that for BPD with a DLI of 15 min, most of the BPD remains in the vasculature and has not yet diffused into the surrounding tissue. As a result, damage of the vasculature is the dominant mechanism of PDT effect after a DLI of 15 min and the measured BPD concentration in tissue is only used as a surrogate to quantify the corresponding BPD concentration in the vasculature. For this reason, the singlet oxygen threshold dose obtained for BPD with a DLI of 15 min will be excluded in our final analysis of in vivo singlet oxygen threshold dose for direct tissue damage due to singlet oxygen.
Uncertainty in singlet oxygen threshold dose determination
The mean values and standard deviations of singlet oxygen threshold dose were determined to be 0. Figure 3 , the mean [ 1 O 2 ] rx,sh is indicated with the black dashed line, and the standard deviation is indicated by the shaded grey region. The points numbered 12 and 13 were disregarded for the analysis due to their lower than physiologically sound PS concentrations compared to other data for similar fluence rate and fluence conditions (represented in data points 2 and 5). In Figure 4 , the data set appears to show two distinct model trends, further illustrating the need for a more detailed study. Most of the data points had extremely large areas of necrosis (with irregular shapes exceeding the boundary of the tumor). The standard deviation of singlet oxygen threshold dose (gray area) is very large and requires further study to improve it. However, it is clear that the [ 1 O 2 ] rx,sh values for a DLI of 15 min is substantially lower than that for a DLI of 3 h.
To examine both the error in the experiments and determine the singlet oxygen threshold dose, all the individual measurements were plotted between the reacted singlet oxygen and necrosis radius. Figure 5 shows all the necrosis results for BPD for a DLI of 3 h ( Figure 5A ) and a DLI of 15 min ( Figure 5B ). From this, it can be concluded that the maximum spread in singlet oxygen threshold dose is 0.07-1.60 mm for BPD with a 3-h DLI and 0.01-0.2 mm for BPD with a 15-min DLI. The upper limit of [ 1 O 2 ] rx,sh in vivo is 1.6 mm and 0.2 mm for BPD with a DLI of 3 h and 15 min, respectively, from our studies ( Figure 5A and B). Table 5 for benzoporphyrin derivative monoacid ring A (BPD) with a drug-light interval of (A) 3 h and (B) 15 min, respectively.
where
is the reacted singlet oxygen concentration when the cell survival is dropped to 1/e, SF is the cell survival fraction of each individual cell (SF = 1 means all cell survive, and SF = 0.1 means 1-in-10-cells survival). Given that one needs to kill k cells to produce an observable necrosis in vivo, then the chance of all k cells not surviving is expressed as:
Inserting Eqn. (14) into Eqn. (15) to produce necrosis or an in-vitro model of MLL cells [19] in which 9 × 10 8 molecules of singlet oxygen per cell were needed to reduce the surviving fraction by 1/e using mTHPC.
Conclusions
It was shown that using a set of rate equations and fitting the data to the necrosis radius in a RIF mouse model, the singlet oxygen threshold dose in vivo can be determined. Preliminary studies have identified that the singlet oxygen threshold dose is in the range of 0.56-0.72 mm for two photosensitizers studied: Photofrin ® and BPD (Table 6 ). This value is about 20 times smaller than that determined in vitro. It is concluded that PDT is more potent in vivo than that in vitro, as was already pointed out by Wang et al. [29] .
